Is a complete INSM research report available?

No complete published report is available for Insmed Incorporated (INSM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Insmed Incorporated (INSM)

NASDAQ: INSM · USD

$104

-0.60 (-0.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first INSM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	22.6B
Revenue (ttm)	819.6M
Net income (ttm)	-1.2B
EPS (ttm)	-$5.70
Shares out	216.8M
Volume	1,945,720
Beta	0.78
Price target	$196	+88.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 819.6M
Net income (ttm): -1.2B
EPS (ttm): -$5.70
Market cap: 22.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All INSM indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001104506
Company name	Insmed Incorporated
Country	United States
Country code	US
Cusip	457669307
Employees	1,664
Employees Change	393%
Employees Change Percent	30.92
Enterprise value	$22.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2000-06-01
Isin	US4576693075
Last refreshed	2026-07-29
Market cap	$22.6B
Market cap category	Large-Cap
Price	$104
Price currency	USD
Rev Per Employee	492,526.44x
Sector	Healthcare
Sector PE	45.13
Sector PE Fwd	23.9
Sic	2834
Symbol	INSM
Website	https://www.insmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.24%
EV Sales Forward	11.32x
EV/Sales	26.95x
FCF yield	-4.08%
P/B ratio	31.99x
P/S ratio	27.54x
PS Forward	11.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-140.56%
EBITDA Margin	-137.99%
Gross margin	81.81%
Gross Profit	$670.5M
Gross Profit Growth	130.04%
Gross Profit Growth Q	261.37%
Gross Profit Growth3 Y	49.49%
Gross Profit Growth5 Y	36.55%
Net Income	$-1.2B
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-143.76%
Profit Margin	-144.44%
Profit Per Employee	$-711,391
ROA	-31.11
Roa5y	-25.98
ROCE	-67.17
ROE	-294.5
ROIC	-42.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	24.81%
Cagr15y	16.09%
Cagr1y	0.17%
Cagr20y	11.6%
Cagr3y	72.16%
Cagr5y	34.33%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	115.09x
Revenue Growth Q	229.62x
Revenue Growth Quarters	21x
Revenue Growth Years	7x
Revenue Growth3 Y	47.1x
Revenue Growth5 Y	37.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.42
Assets	$2.1B
Cash	$1.2B
Current Assets	$1.6B
Current Liabilities	$361M
Debt	$742.5M
Debt Equity	$1.05
Equity	$704.9M
Interest Coverage	-14
Liabilities	$1.4B
Long Term Assets	$462.7M
Long Term Liabilities	$1B
Net Cash	$481.1M
Net Cash By Market Cap	$2.13
Net Debt Equity	$-0.68
Tangible Book Value	$495M
Tangible Book Value Per Share	$2.29
WACC	8.53

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.47
Inventory Turnover	1.28
Net Working Capital	$37.1M
Quick ratio	3.88
Working Capital	$1.3B
Working Capital Turnover	$0.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.64%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	816.64%
1Y total return	0.17%
200-day SMA	148.5
3Y total return	410.44%
50-day SMA	105.3
50-day SMA vs 200-day SMA	50under200
5Y total return	337.34%
All Time High	212.8
All Time High Change	-51.06%
All Time High Date	2025-12-02
All Time Low	2.64
All Time Low Change	3,844.32%
All Time Low Date	2011-11-25
ATR	4.14
Beta	0.78
Beta1y	0.27
Beta2y	0.79
Ch YTD	-40.17
High	105.8
High52	212.8
High52 Date	2025-12-02
High52ch	-51.06%
Low	103.2
Low52	90.39
Low52 Date	2026-06-10
Low52ch	15.2%
Ma50ch	-1.11%
Premarket Change Percent	-0.16
Premarket Price	$105
Premarket Volume	981
Price vs 200-day SMA	-29.9%
RSI	42.76
RSI Monthly	48.61
RSI Weekly	38.84
Sharpe ratio	0.2x
Sortino ratio	0.37
Total Return	-20.64%
Tr YTD	-40.17
Tr15y	837.26%
Tr1m	0.73%
Tr1w	-4.13%
Tr3m	-23.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	23
Analyst Count Top	14
Analyst Price Target Top	$197
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.74
Earnings Revenue Estimate	389,260,496x
Earnings Revenue Estimate Growth	262.39x
Operating Income	$-965.2M
Operating margin	-117.8
Price target	$196
Price Target Change	$88.4
Price Target Change Top	$89.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	198,422,574%
Float Percent	91.54%
Net Borrowing	-5,019,000
Shares Insiders	0.66%
Shares Institutions	96.47%
Shares Out	216,752,451
Shares Qo Q	0.86%
Shares Yo Y	20.64%
Short Float	5.86%
Short Ratio	2.8
Short Shares	5.36

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-1.1B
Adjusted OCF	-1,054,866,000
Average Volume	2,332,429.65x
Bv Per Share	3.26
CAPEX	$-26M
Ch10y	816.6
Ch15y	837.3
Ch1m	0.73
Ch1w	-4.13
Ch1y	0.17
Ch20y	797.7
Ch3m	-23.42
Ch3y	410.4
Ch5y	337.3
Ch6m	-35.98
Change	-0.57%
Change From Open	-0.57
Close	104.7
Days Gap	0
Depreciation Amortization	16,181,000
Dollar Volume	202,607,823.6
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-1.2B
EBITDA	$-1.1B
EPS	$-5.7
F Score	4
FCF	$-921.6M
FCF EV Yield	-4.17x
FCF Per Share	$-4.25
Financing CF	954,589,000
Fiscal Year End	December
Founded	1,988
Goodwill	136,110,000
Income Tax	$5.6M
Investing CF	120,533,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2011-03-03
Last Split Type	Reverse
Last10k Filing Date	2026-02-19
Ma150	135.8
Ma150ch	-23.35%
Ma20	109.5
Ma20ch	-4.92%
Net CF	178,941,000
Next Earnings Date	2026-08-06
Open	104.7
Optionable	Yes
Position In Range	36.82
Post Close	104.1
Postmarket Change Percent	-0.61
Postmarket Price	$104
Ppne	204,233,000
Pre Close	104.7
Price Date	2026-07-28
Ptbv Ratio	45.6
Relative Volume	0.83x
Revenue	819,564,000x
SBC By Revenue	19.43x
Share Based Comp	159,202,000
Tax By Revenue	0.68x
Tr20y	797.67%
Tr6m	-35.98%
Us State	New Jersey
Volume	1,945,720
Z Score	7.82

Insmed Incorporated (INSM)

Coverage state: Market snapshot only — no published research

Generate the first INSM analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · INSM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INSM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on INSM

Frequently asked questions